Role of Co-trimoxazole in Severe COVID-19 Patients

NCT04470531 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Severe COVID-19 Patients

Interventions

DRUG: oral co-trimoxazole

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Collaborators

[object Object]
[object Object]